PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Online information about risks and benefits of screening mammography in 10 European countries: An observational Web sites analysis.

Abstract Most publications about breast cancer do not provide accurate and comprehensive information, giving few or no data about risk/benefit ratios. We conducted a comparative study among 10 European countries about health information on breast cancer screening, assessing the first 10 Web sites addressing the general public that appeared following an Internet search.With the help of medical residents involved in the EuroNet MRPH Association, we analyzed the first 30 results of an Internet search in 10 European countries to determine the first 10 sites that offered screening mammography. We searched for the following information: source of information, general information on mammography and breast cancer screening, potential harms and risks (false positives, false positives after biopsy, false negatives, interval cancer, overdiagnosis, lead-time bias, and radiation exposure), and potential benefits (reduced mortality and increased survival).The United Kingdom provided the most information: 39 of all 70 possible identified risks (56%) were reported on its sites. Five nations presented over 35% of the possible information (United Kingdom, Spain, France, Ireland, and Italy); the others were under 30% (Portugal, Poland, Slovenia, Netherlands, and Croatia). Regarding the benefits, sites offering the most complete information were those in France (95%) and Poland (90%).Our results suggest that, despite consensus in the scientific community about providing better information to citizens, further efforts are needed to improve information about breast cancer screening. That conclusion also applies to countries showing better results. We believe that there should be greater coordination in this regard throughout Europe.
PMID
Related Publications

Information provided by Italian breast cancer screening programmes: a comparison between 2001 and 2014.

The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.

Scarce information about breast cancer screening: An Italian websites analysis.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29851843
OWN - NLM
STAT- MEDLINE
DCOM- 20180612
LR  - 20180612
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 22
DP  - 2018 Jun
TI  - Online information about risks and benefits of screening mammography in 10
      European countries: An observational Web sites analysis.
PG  - e10957
LID - 10.1097/MD.0000000000010957 [doi]
AB  - Most publications about breast cancer do not provide accurate and comprehensive
      information, giving few or no data about risk/benefit ratios. We conducted a
      comparative study among 10 European countries about health information on breast 
      cancer screening, assessing the first 10 Web sites addressing the general public 
      that appeared following an Internet search.With the help of medical residents
      involved in the EuroNet MRPH Association, we analyzed the first 30 results of an 
      Internet search in 10 European countries to determine the first 10 sites that
      offered screening mammography. We searched for the following information: source 
      of information, general information on mammography and breast cancer screening,
      potential harms and risks (false positives, false positives after biopsy, false
      negatives, interval cancer, overdiagnosis, lead-time bias, and radiation
      exposure), and potential benefits (reduced mortality and increased survival).The 
      United Kingdom provided the most information: 39 of all 70 possible identified
      risks (56%) were reported on its sites. Five nations presented over 35% of the
      possible information (United Kingdom, Spain, France, Ireland, and Italy); the
      others were under 30% (Portugal, Poland, Slovenia, Netherlands, and Croatia).
      Regarding the benefits, sites offering the most complete information were those
      in France (95%) and Poland (90%).Our results suggest that, despite consensus in
      the scientific community about providing better information to citizens, further 
      efforts are needed to improve information about breast cancer screening. That
      conclusion also applies to countries showing better results. We believe that
      there should be greater coordination in this regard throughout Europe.
FAU - Spagnoli, Laura
AU  - Spagnoli L
AD  - Department of Experimental Medicine, University of Campania "Luigi Vanvitelli",
      Naples, Italy.
FAU - Navaro, Monica
AU  - Navaro M
FAU - Ferrara, Pietro
AU  - Ferrara P
FAU - Del Prete, Viola
AU  - Del Prete V
FAU - Attena, Francesco
AU  - Attena F
CN  - and the Collaborative Working Group
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Observational Study
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - AIM
SB  - IM
MH  - Breast Neoplasms/*diagnosis
MH  - Early Detection of Cancer/methods/*statistics & numerical data
MH  - Europe
MH  - Female
MH  - Health Education/*statistics & numerical data
MH  - Humans
MH  - Internet/statistics & numerical data
MH  - Mammography/*statistics & numerical data
MH  - Risk Assessment/statistics & numerical data
EDAT- 2018/06/01 06:00
MHDA- 2018/06/13 06:00
CRDT- 2018/06/01 06:00
PHST- 2018/06/01 06:00 [entrez]
PHST- 2018/06/01 06:00 [pubmed]
PHST- 2018/06/13 06:00 [medline]
AID - 10.1097/MD.0000000000010957 [doi]
AID - 00005792-201806010-00071 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 Jun;97(22):e10957. doi: 10.1097/MD.0000000000010957.